Fennec Pharmaceuticals Inc.
FRX.TO
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.79M | -637.00K | -3.15M | -1.17M | -1.99M |
| Total Depreciation and Amortization | -77.00K | 26.00K | 25.00K | 26.00K | -774.00K |
| Total Amortization of Deferred Charges | 27.00K | 12.00K | 13.00K | 13.00K | 95.00K |
| Total Other Non-Cash Items | 7.97M | 547.00K | 2.64M | 878.00K | 1.14M |
| Change in Net Operating Assets | -9.10M | 1.55M | -3.21M | -4.07M | 52.00K |
| Cash from Operations | -5.96M | 1.49M | -3.69M | -4.32M | -1.47M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -19.48M | -- | -- | -- | -13.00M |
| Issuance of Common Stock | 42.25M | 1.80M | -- | 371.00K | 797.00K |
| Repurchase of Common Stock | -26.00K | -50.00K | -284.00K | -12.00K | -9.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.95M | -- | -- | -- | 0.00 |
| Cash from Financing | 20.80M | 1.75M | -284.00K | 359.00K | -12.21M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.84M | 3.24M | -3.97M | -3.96M | -13.69M |